Effects of miR-193a and sorafenib on hepatocellular carcinoma cells

BACKGROUND: Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance, it is the third most common cause of cancer-related mortality worldwide. In the last years the multikinase inhibitor sorafenib has been used for advanced HCC, but some patients do not benefit from this thera...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Salvi, Alessandro, Conde, Isabel, Abeni, Edoardo, Arici, Bruna, Grossi, Ilaria, Specchia, Claudia, Portolani, Nazario, Barlati, Sergio, De Petro, Giuseppina
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029516/
https://ncbi.nlm.nih.gov/pubmed/24330766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-12-162
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items